nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—migraine—Prednisone—atopic dermatitis	0.705	1	CpDpCtD
Methylergometrine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0393	0.258	CbGbCtD
Methylergometrine—CYP3A4—Tacrolimus—atopic dermatitis	0.0234	0.153	CbGbCtD
Methylergometrine—CYP3A4—Loratadine—atopic dermatitis	0.0171	0.112	CbGbCtD
Methylergometrine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0157	0.103	CbGbCtD
Methylergometrine—CYP3A4—Triamcinolone—atopic dermatitis	0.0119	0.0778	CbGbCtD
Methylergometrine—CYP3A4—Betamethasone—atopic dermatitis	0.0102	0.0668	CbGbCtD
Methylergometrine—CYP3A4—Prednisolone—atopic dermatitis	0.01	0.0659	CbGbCtD
Methylergometrine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00952	0.0624	CbGbCtD
Methylergometrine—CYP3A4—Prednisone—atopic dermatitis	0.00949	0.0622	CbGbCtD
Methylergometrine—CYP3A4—Dexamethasone—atopic dermatitis	0.00592	0.0388	CbGbCtD
Methylergometrine—Tinnitus—Diphenhydramine—atopic dermatitis	0.000962	0.00951	CcSEcCtD
Methylergometrine—Thrombophlebitis—Tacrolimus—atopic dermatitis	0.000906	0.00896	CcSEcCtD
Methylergometrine—Nasal congestion—Tacrolimus—atopic dermatitis	0.000861	0.00851	CcSEcCtD
Methylergometrine—Nervous system disorder—Fluocinonide—atopic dermatitis	0.000797	0.00788	CcSEcCtD
Methylergometrine—Palpitations—Diphenhydramine—atopic dermatitis	0.000794	0.00785	CcSEcCtD
Methylergometrine—Palpitations—Dimenhydrinate—atopic dermatitis	0.000794	0.00785	CcSEcCtD
Methylergometrine—Convulsion—Dimenhydrinate—atopic dermatitis	0.000778	0.00769	CcSEcCtD
Methylergometrine—Convulsion—Diphenhydramine—atopic dermatitis	0.000778	0.00769	CcSEcCtD
Methylergometrine—Tinnitus—Loratadine—atopic dermatitis	0.000741	0.00732	CcSEcCtD
Methylergometrine—Tachycardia—Diphenhydramine—atopic dermatitis	0.000715	0.00707	CcSEcCtD
Methylergometrine—Tachycardia—Dimenhydrinate—atopic dermatitis	0.000715	0.00707	CcSEcCtD
Methylergometrine—Anaphylactic shock—Pimecrolimus—atopic dermatitis	0.000709	0.00701	CcSEcCtD
Methylergometrine—Hyperhidrosis—Dimenhydrinate—atopic dermatitis	0.000709	0.00701	CcSEcCtD
Methylergometrine—Hyperhidrosis—Diphenhydramine—atopic dermatitis	0.000709	0.00701	CcSEcCtD
Methylergometrine—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.000695	0.00687	CcSEcCtD
Methylergometrine—Hypotension—Dimenhydrinate—atopic dermatitis	0.000685	0.00677	CcSEcCtD
Methylergometrine—Hypotension—Diphenhydramine—atopic dermatitis	0.000685	0.00677	CcSEcCtD
Methylergometrine—Angina pectoris—Tacrolimus—atopic dermatitis	0.000661	0.00653	CcSEcCtD
Methylergometrine—Sweating increased—Tacrolimus—atopic dermatitis	0.000661	0.00653	CcSEcCtD
Methylergometrine—Paraesthesia—Diphenhydramine—atopic dermatitis	0.000658	0.00651	CcSEcCtD
Methylergometrine—Paraesthesia—Dimenhydrinate—atopic dermatitis	0.000658	0.00651	CcSEcCtD
Methylergometrine—Paraesthesia—Pimecrolimus—atopic dermatitis	0.000636	0.00629	CcSEcCtD
Methylergometrine—Rash—Desonide—atopic dermatitis	0.000633	0.00625	CcSEcCtD
Methylergometrine—Dermatitis—Desonide—atopic dermatitis	0.000632	0.00625	CcSEcCtD
Methylergometrine—Dyspnoea—Pimecrolimus—atopic dermatitis	0.000632	0.00625	CcSEcCtD
Methylergometrine—Headache—Desonide—atopic dermatitis	0.000629	0.00621	CcSEcCtD
Methylergometrine—Palpitations—Loratadine—atopic dermatitis	0.000611	0.00604	CcSEcCtD
Methylergometrine—Hypertension—Loratadine—atopic dermatitis	0.000597	0.0059	CcSEcCtD
Methylergometrine—Chest pain—Loratadine—atopic dermatitis	0.000589	0.00582	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.00058	0.00573	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisolone—atopic dermatitis	0.000579	0.00572	CcSEcCtD
Methylergometrine—Haematuria—Tacrolimus—atopic dermatitis	0.000577	0.0057	CcSEcCtD
Methylergometrine—Thrombophlebitis—Hydrocortisone—atopic dermatitis	0.000565	0.00559	CcSEcCtD
Methylergometrine—Anaphylactic shock—Loratadine—atopic dermatitis	0.000565	0.00558	CcSEcCtD
Methylergometrine—Abdominal pain—Pimecrolimus—atopic dermatitis	0.00056	0.00554	CcSEcCtD
Methylergometrine—Nervous system disorder—Loratadine—atopic dermatitis	0.000554	0.00547	CcSEcCtD
Methylergometrine—Bradycardia—Tacrolimus—atopic dermatitis	0.000553	0.00546	CcSEcCtD
Methylergometrine—Tachycardia—Loratadine—atopic dermatitis	0.000551	0.00545	CcSEcCtD
Methylergometrine—Hallucination—Tacrolimus—atopic dermatitis	0.00054	0.00534	CcSEcCtD
Methylergometrine—Dizziness—Fluocinonide—atopic dermatitis	0.000538	0.00532	CcSEcCtD
Methylergometrine—Thrombophlebitis—Triamcinolone—atopic dermatitis	0.000532	0.00526	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methylprednisolone—atopic dermatitis	0.000531	0.00525	CcSEcCtD
Methylergometrine—Hypotension—Loratadine—atopic dermatitis	0.000528	0.00522	CcSEcCtD
Methylergometrine—Rash—Fluocinonide—atopic dermatitis	0.000513	0.00507	CcSEcCtD
Methylergometrine—Dermatitis—Fluocinonide—atopic dermatitis	0.000512	0.00506	CcSEcCtD
Methylergometrine—Headache—Fluocinonide—atopic dermatitis	0.000509	0.00504	CcSEcCtD
Methylergometrine—Paraesthesia—Loratadine—atopic dermatitis	0.000507	0.00501	CcSEcCtD
Methylergometrine—Tinnitus—Tacrolimus—atopic dermatitis	0.000506	0.005	CcSEcCtD
Methylergometrine—Chest pain—Mometasone—atopic dermatitis	0.000505	0.005	CcSEcCtD
Methylergometrine—Cardiac disorder—Tacrolimus—atopic dermatitis	0.000504	0.00498	CcSEcCtD
Methylergometrine—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000502	0.00496	CcSEcCtD
Methylergometrine—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000502	0.00496	CcSEcCtD
Methylergometrine—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.000498	0.00492	CcSEcCtD
Methylergometrine—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000485	0.00479	CcSEcCtD
Methylergometrine—Dizziness—Dimenhydrinate—atopic dermatitis	0.000485	0.00479	CcSEcCtD
Methylergometrine—Dizziness—Diphenhydramine—atopic dermatitis	0.000485	0.00479	CcSEcCtD
Methylergometrine—Anaphylactic shock—Mometasone—atopic dermatitis	0.000485	0.00479	CcSEcCtD
Methylergometrine—Thrombophlebitis—Dexamethasone—atopic dermatitis	0.000483	0.00478	CcSEcCtD
Methylergometrine—Thrombophlebitis—Betamethasone—atopic dermatitis	0.000483	0.00478	CcSEcCtD
Methylergometrine—Vomiting—Dimenhydrinate—atopic dermatitis	0.000466	0.00461	CcSEcCtD
Methylergometrine—Vomiting—Diphenhydramine—atopic dermatitis	0.000466	0.00461	CcSEcCtD
Methylergometrine—Rash—Dimenhydrinate—atopic dermatitis	0.000462	0.00457	CcSEcCtD
Methylergometrine—Rash—Diphenhydramine—atopic dermatitis	0.000462	0.00457	CcSEcCtD
Methylergometrine—Dermatitis—Diphenhydramine—atopic dermatitis	0.000462	0.00457	CcSEcCtD
Methylergometrine—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000462	0.00457	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000462	0.00456	CcSEcCtD
Methylergometrine—Headache—Dimenhydrinate—atopic dermatitis	0.000459	0.00454	CcSEcCtD
Methylergometrine—Headache—Diphenhydramine—atopic dermatitis	0.000459	0.00454	CcSEcCtD
Methylergometrine—Muscle spasms—Tacrolimus—atopic dermatitis	0.000454	0.00449	CcSEcCtD
Methylergometrine—Vomiting—Pimecrolimus—atopic dermatitis	0.000451	0.00446	CcSEcCtD
Methylergometrine—Rash—Pimecrolimus—atopic dermatitis	0.000447	0.00442	CcSEcCtD
Methylergometrine—Dermatitis—Pimecrolimus—atopic dermatitis	0.000447	0.00441	CcSEcCtD
Methylergometrine—Abdominal pain—Loratadine—atopic dermatitis	0.000446	0.00441	CcSEcCtD
Methylergometrine—Headache—Pimecrolimus—atopic dermatitis	0.000444	0.00439	CcSEcCtD
Methylergometrine—Nausea—Dimenhydrinate—atopic dermatitis	0.000435	0.0043	CcSEcCtD
Methylergometrine—Nausea—Diphenhydramine—atopic dermatitis	0.000435	0.0043	CcSEcCtD
Methylergometrine—Paraesthesia—Mometasone—atopic dermatitis	0.000435	0.0043	CcSEcCtD
Methylergometrine—Dyspnoea—Mometasone—atopic dermatitis	0.000432	0.00427	CcSEcCtD
Methylergometrine—Sweating increased—Prednisolone—atopic dermatitis	0.000422	0.00417	CcSEcCtD
Methylergometrine—Nausea—Pimecrolimus—atopic dermatitis	0.000421	0.00416	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisone—atopic dermatitis	0.000421	0.00416	CcSEcCtD
Methylergometrine—Palpitations—Tacrolimus—atopic dermatitis	0.000418	0.00413	CcSEcCtD
Methylergometrine—Sweating increased—Hydrocortisone—atopic dermatitis	0.000412	0.00407	CcSEcCtD
Methylergometrine—Convulsion—Tacrolimus—atopic dermatitis	0.000409	0.00405	CcSEcCtD
Methylergometrine—Hypertension—Tacrolimus—atopic dermatitis	0.000408	0.00403	CcSEcCtD
Methylergometrine—Chest pain—Tacrolimus—atopic dermatitis	0.000402	0.00398	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000396	0.00392	CcSEcCtD
Methylergometrine—Sweating increased—Triamcinolone—atopic dermatitis	0.000388	0.00384	CcSEcCtD
Methylergometrine—Sweating increased—Methylprednisolone—atopic dermatitis	0.000387	0.00383	CcSEcCtD
Methylergometrine—Diarrhoea—Loratadine—atopic dermatitis	0.000386	0.00382	CcSEcCtD
Methylergometrine—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000386	0.00381	CcSEcCtD
Methylergometrine—Abdominal pain—Mometasone—atopic dermatitis	0.000383	0.00379	CcSEcCtD
Methylergometrine—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000378	0.00374	CcSEcCtD
Methylergometrine—Tachycardia—Tacrolimus—atopic dermatitis	0.000376	0.00372	CcSEcCtD
Methylergometrine—Dizziness—Loratadine—atopic dermatitis	0.000373	0.00369	CcSEcCtD
Methylergometrine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000373	0.00369	CcSEcCtD
Methylergometrine—Hypotension—Tacrolimus—atopic dermatitis	0.00036	0.00356	CcSEcCtD
Methylergometrine—Vomiting—Loratadine—atopic dermatitis	0.000359	0.00355	CcSEcCtD
Methylergometrine—Rash—Loratadine—atopic dermatitis	0.000356	0.00352	CcSEcCtD
Methylergometrine—Dermatitis—Loratadine—atopic dermatitis	0.000356	0.00352	CcSEcCtD
Methylergometrine—Headache—Loratadine—atopic dermatitis	0.000354	0.0035	CcSEcCtD
Methylergometrine—Bradycardia—Prednisolone—atopic dermatitis	0.000353	0.00349	CcSEcCtD
Methylergometrine—Sweating increased—Dexamethasone—atopic dermatitis	0.000352	0.00348	CcSEcCtD
Methylergometrine—Sweating increased—Betamethasone—atopic dermatitis	0.000352	0.00348	CcSEcCtD
Methylergometrine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000347	0.00343	CcSEcCtD
Methylergometrine—Paraesthesia—Tacrolimus—atopic dermatitis	0.000346	0.00342	CcSEcCtD
Methylergometrine—Bradycardia—Hydrocortisone—atopic dermatitis	0.000345	0.00341	CcSEcCtD
Methylergometrine—Dyspnoea—Tacrolimus—atopic dermatitis	0.000344	0.0034	CcSEcCtD
Methylergometrine—Hallucination—Hydrocortisone—atopic dermatitis	0.000337	0.00333	CcSEcCtD
Methylergometrine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000336	0.00332	CcSEcCtD
Methylergometrine—Nausea—Loratadine—atopic dermatitis	0.000335	0.00332	CcSEcCtD
Methylergometrine—Diarrhoea—Mometasone—atopic dermatitis	0.000332	0.00328	CcSEcCtD
Methylergometrine—Bradycardia—Triamcinolone—atopic dermatitis	0.000325	0.00321	CcSEcCtD
Methylergometrine—Bradycardia—Methylprednisolone—atopic dermatitis	0.000324	0.0032	CcSEcCtD
Methylergometrine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000323	0.00319	CcSEcCtD
Methylergometrine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.00032	0.00316	CcSEcCtD
Methylergometrine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00032	0.00316	CcSEcCtD
Methylergometrine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000318	0.00314	CcSEcCtD
Methylergometrine—Hallucination—Methylprednisolone—atopic dermatitis	0.000317	0.00313	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000315	0.00312	CcSEcCtD
Methylergometrine—Vomiting—Mometasone—atopic dermatitis	0.000308	0.00305	CcSEcCtD
Methylergometrine—Sweating increased—Prednisone—atopic dermatitis	0.000307	0.00303	CcSEcCtD
Methylergometrine—Rash—Mometasone—atopic dermatitis	0.000305	0.00302	CcSEcCtD
Methylergometrine—Dermatitis—Mometasone—atopic dermatitis	0.000305	0.00302	CcSEcCtD
Methylergometrine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000305	0.00301	CcSEcCtD
Methylergometrine—Headache—Mometasone—atopic dermatitis	0.000304	0.003	CcSEcCtD
Methylergometrine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000301	0.00298	CcSEcCtD
Methylergometrine—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000295	0.00292	CcSEcCtD
Methylergometrine—Bradycardia—Dexamethasone—atopic dermatitis	0.000295	0.00291	CcSEcCtD
Methylergometrine—Bradycardia—Betamethasone—atopic dermatitis	0.000295	0.00291	CcSEcCtD
Methylergometrine—Hallucination—Dexamethasone—atopic dermatitis	0.000288	0.00285	CcSEcCtD
Methylergometrine—Hallucination—Betamethasone—atopic dermatitis	0.000288	0.00285	CcSEcCtD
Methylergometrine—Nausea—Mometasone—atopic dermatitis	0.000288	0.00285	CcSEcCtD
Methylergometrine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000264	0.00261	CcSEcCtD
Methylergometrine—Convulsion—Prednisolone—atopic dermatitis	0.000261	0.00259	CcSEcCtD
Methylergometrine—Hypertension—Prednisolone—atopic dermatitis	0.000261	0.00258	CcSEcCtD
Methylergometrine—Bradycardia—Prednisone—atopic dermatitis	0.000256	0.00254	CcSEcCtD
Methylergometrine—Convulsion—Hydrocortisone—atopic dermatitis	0.000255	0.00252	CcSEcCtD
Methylergometrine—Dizziness—Tacrolimus—atopic dermatitis	0.000255	0.00252	CcSEcCtD
Methylergometrine—Hypertension—Hydrocortisone—atopic dermatitis	0.000254	0.00252	CcSEcCtD
Methylergometrine—Hallucination—Prednisone—atopic dermatitis	0.000251	0.00248	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000246	0.00244	CcSEcCtD
Methylergometrine—Vomiting—Tacrolimus—atopic dermatitis	0.000245	0.00242	CcSEcCtD
Methylergometrine—Rash—Tacrolimus—atopic dermatitis	0.000243	0.0024	CcSEcCtD
Methylergometrine—Dermatitis—Tacrolimus—atopic dermatitis	0.000243	0.0024	CcSEcCtD
Methylergometrine—Headache—Tacrolimus—atopic dermatitis	0.000242	0.00239	CcSEcCtD
Methylergometrine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000241	0.00238	CcSEcCtD
Methylergometrine—Convulsion—Triamcinolone—atopic dermatitis	0.00024	0.00238	CcSEcCtD
Methylergometrine—Tachycardia—Prednisolone—atopic dermatitis	0.00024	0.00238	CcSEcCtD
Methylergometrine—Convulsion—Methylprednisolone—atopic dermatitis	0.00024	0.00237	CcSEcCtD
Methylergometrine—Hypertension—Triamcinolone—atopic dermatitis	0.00024	0.00237	CcSEcCtD
Methylergometrine—Hypertension—Methylprednisolone—atopic dermatitis	0.000239	0.00236	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000238	0.00235	CcSEcCtD
Methylergometrine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000236	0.00233	CcSEcCtD
Methylergometrine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000235	0.00232	CcSEcCtD
Methylergometrine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000233	0.0023	CcSEcCtD
Methylergometrine—Nausea—Tacrolimus—atopic dermatitis	0.000229	0.00226	CcSEcCtD
Methylergometrine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000227	0.00224	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000226	0.00223	CcSEcCtD
Methylergometrine—Hypotension—Hydrocortisone—atopic dermatitis	0.000225	0.00222	CcSEcCtD
Methylergometrine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000222	0.00219	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisolone—atopic dermatitis	0.000221	0.00219	CcSEcCtD
Methylergometrine—Tachycardia—Triamcinolone—atopic dermatitis	0.000221	0.00219	CcSEcCtD
Methylergometrine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000221	0.00218	CcSEcCtD
Methylergometrine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000219	0.00216	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000218	0.00216	CcSEcCtD
Methylergometrine—Convulsion—Betamethasone—atopic dermatitis	0.000218	0.00216	CcSEcCtD
Methylergometrine—Convulsion—Dexamethasone—atopic dermatitis	0.000218	0.00216	CcSEcCtD
Methylergometrine—Hypertension—Dexamethasone—atopic dermatitis	0.000217	0.00215	CcSEcCtD
Methylergometrine—Hypertension—Betamethasone—atopic dermatitis	0.000217	0.00215	CcSEcCtD
Methylergometrine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000216	0.00214	CcSEcCtD
Methylergometrine—Hypotension—Methylprednisolone—atopic dermatitis	0.000211	0.00209	CcSEcCtD
Methylergometrine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000206	0.00203	CcSEcCtD
Methylergometrine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000206	0.00203	CcSEcCtD
Methylergometrine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000203	0.00201	CcSEcCtD
Methylergometrine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000203	0.00201	CcSEcCtD
Methylergometrine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000202	0.002	CcSEcCtD
Methylergometrine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000202	0.00199	CcSEcCtD
Methylergometrine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000202	0.00199	CcSEcCtD
Methylergometrine—Tachycardia—Betamethasone—atopic dermatitis	0.000201	0.00198	CcSEcCtD
Methylergometrine—Tachycardia—Dexamethasone—atopic dermatitis	0.000201	0.00198	CcSEcCtD
Methylergometrine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000199	0.00196	CcSEcCtD
Methylergometrine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000199	0.00196	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000197	0.00194	CcSEcCtD
Methylergometrine—Hypotension—Betamethasone—atopic dermatitis	0.000192	0.0019	CcSEcCtD
Methylergometrine—Hypotension—Dexamethasone—atopic dermatitis	0.000192	0.0019	CcSEcCtD
Methylergometrine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.00019	0.00188	CcSEcCtD
Methylergometrine—Convulsion—Prednisone—atopic dermatitis	0.00019	0.00188	CcSEcCtD
Methylergometrine—Hypertension—Prednisone—atopic dermatitis	0.000189	0.00187	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000185	0.00183	CcSEcCtD
Methylergometrine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000185	0.00182	CcSEcCtD
Methylergometrine—Paraesthesia—Betamethasone—atopic dermatitis	0.000185	0.00182	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisone—atopic dermatitis	0.000179	0.00177	CcSEcCtD
Methylergometrine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000179	0.00177	CcSEcCtD
Methylergometrine—Nervous system disorder—Prednisone—atopic dermatitis	0.000176	0.00174	CcSEcCtD
Methylergometrine—Tachycardia—Prednisone—atopic dermatitis	0.000175	0.00173	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000173	0.00171	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000168	0.00166	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000168	0.00166	CcSEcCtD
Methylergometrine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000165	0.00163	CcSEcCtD
Methylergometrine—Dizziness—Prednisolone—atopic dermatitis	0.000163	0.00161	CcSEcCtD
Methylergometrine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000162	0.00161	CcSEcCtD
Methylergometrine—Abdominal pain—Betamethasone—atopic dermatitis	0.000162	0.00161	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisone—atopic dermatitis	0.000161	0.00159	CcSEcCtD
Methylergometrine—Dizziness—Hydrocortisone—atopic dermatitis	0.000159	0.00157	CcSEcCtD
Methylergometrine—Rash—Prednisolone—atopic dermatitis	0.000155	0.00154	CcSEcCtD
Methylergometrine—Dermatitis—Prednisolone—atopic dermatitis	0.000155	0.00153	CcSEcCtD
Methylergometrine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000155	0.00153	CcSEcCtD
Methylergometrine—Headache—Prednisolone—atopic dermatitis	0.000154	0.00153	CcSEcCtD
Methylergometrine—Vomiting—Hydrocortisone—atopic dermatitis	0.000153	0.00151	CcSEcCtD
Methylergometrine—Rash—Hydrocortisone—atopic dermatitis	0.000152	0.0015	CcSEcCtD
Methylergometrine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000152	0.0015	CcSEcCtD
Methylergometrine—Headache—Hydrocortisone—atopic dermatitis	0.000151	0.00149	CcSEcCtD
Methylergometrine—Dizziness—Triamcinolone—atopic dermatitis	0.00015	0.00148	CcSEcCtD
Methylergometrine—Dizziness—Methylprednisolone—atopic dermatitis	0.000149	0.00148	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000146	0.00145	CcSEcCtD
Methylergometrine—Nausea—Prednisolone—atopic dermatitis	0.000146	0.00145	CcSEcCtD
Methylergometrine—Vomiting—Triamcinolone—atopic dermatitis	0.000144	0.00142	CcSEcCtD
Methylergometrine—Vomiting—Methylprednisolone—atopic dermatitis	0.000144	0.00142	CcSEcCtD
Methylergometrine—Nausea—Hydrocortisone—atopic dermatitis	0.000143	0.00141	CcSEcCtD
Methylergometrine—Rash—Triamcinolone—atopic dermatitis	0.000143	0.00141	CcSEcCtD
Methylergometrine—Dermatitis—Triamcinolone—atopic dermatitis	0.000143	0.00141	CcSEcCtD
Methylergometrine—Rash—Methylprednisolone—atopic dermatitis	0.000143	0.00141	CcSEcCtD
Methylergometrine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000142	0.00141	CcSEcCtD
Methylergometrine—Headache—Triamcinolone—atopic dermatitis	0.000142	0.0014	CcSEcCtD
Methylergometrine—Headache—Methylprednisolone—atopic dermatitis	0.000142	0.0014	CcSEcCtD
Methylergometrine—Abdominal pain—Prednisone—atopic dermatitis	0.000141	0.0014	CcSEcCtD
Methylergometrine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000141	0.00139	CcSEcCtD
Methylergometrine—Diarrhoea—Betamethasone—atopic dermatitis	0.000141	0.00139	CcSEcCtD
Methylergometrine—Dizziness—Betamethasone—atopic dermatitis	0.000136	0.00134	CcSEcCtD
Methylergometrine—Dizziness—Dexamethasone—atopic dermatitis	0.000136	0.00134	CcSEcCtD
Methylergometrine—Nausea—Triamcinolone—atopic dermatitis	0.000135	0.00133	CcSEcCtD
Methylergometrine—Nausea—Methylprednisolone—atopic dermatitis	0.000134	0.00133	CcSEcCtD
Methylergometrine—Vomiting—Dexamethasone—atopic dermatitis	0.000131	0.00129	CcSEcCtD
Methylergometrine—Vomiting—Betamethasone—atopic dermatitis	0.000131	0.00129	CcSEcCtD
Methylergometrine—Rash—Dexamethasone—atopic dermatitis	0.00013	0.00128	CcSEcCtD
Methylergometrine—Rash—Betamethasone—atopic dermatitis	0.00013	0.00128	CcSEcCtD
Methylergometrine—Dermatitis—Dexamethasone—atopic dermatitis	0.000129	0.00128	CcSEcCtD
Methylergometrine—Dermatitis—Betamethasone—atopic dermatitis	0.000129	0.00128	CcSEcCtD
Methylergometrine—Headache—Betamethasone—atopic dermatitis	0.000129	0.00127	CcSEcCtD
Methylergometrine—Headache—Dexamethasone—atopic dermatitis	0.000129	0.00127	CcSEcCtD
Methylergometrine—Diarrhoea—Prednisone—atopic dermatitis	0.000122	0.00121	CcSEcCtD
Methylergometrine—Nausea—Betamethasone—atopic dermatitis	0.000122	0.00121	CcSEcCtD
Methylergometrine—Nausea—Dexamethasone—atopic dermatitis	0.000122	0.00121	CcSEcCtD
Methylergometrine—Dizziness—Prednisone—atopic dermatitis	0.000118	0.00117	CcSEcCtD
Methylergometrine—Vomiting—Prednisone—atopic dermatitis	0.000114	0.00113	CcSEcCtD
Methylergometrine—Rash—Prednisone—atopic dermatitis	0.000113	0.00112	CcSEcCtD
Methylergometrine—Dermatitis—Prednisone—atopic dermatitis	0.000113	0.00111	CcSEcCtD
Methylergometrine—Headache—Prednisone—atopic dermatitis	0.000112	0.00111	CcSEcCtD
Methylergometrine—Nausea—Prednisone—atopic dermatitis	0.000106	0.00105	CcSEcCtD
Methylergometrine—HTR2C—GPCR ligand binding—CXCL10—atopic dermatitis	5.69e-05	0.00136	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CCR3—atopic dermatitis	5.64e-05	0.00135	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—CXCL8—atopic dermatitis	5.62e-05	0.00135	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—STAT6—atopic dermatitis	5.6e-05	0.00134	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	5.59e-05	0.00134	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—CCL5—atopic dermatitis	5.5e-05	0.00132	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—CCR5—atopic dermatitis	5.47e-05	0.00131	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCL17—atopic dermatitis	5.46e-05	0.00131	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL22—atopic dermatitis	5.43e-05	0.0013	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CCR3—atopic dermatitis	5.32e-05	0.00127	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	5.31e-05	0.00127	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—CXCL8—atopic dermatitis	5.3e-05	0.00127	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—CCL5—atopic dermatitis	5.3e-05	0.00127	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—CCR5—atopic dermatitis	5.25e-05	0.00126	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—CCR5—atopic dermatitis	5.16e-05	0.00124	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CCR3—atopic dermatitis	5.14e-05	0.00123	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL27—atopic dermatitis	5.13e-05	0.00123	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—MAPK8—atopic dermatitis	5.13e-05	0.00123	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CCR3—atopic dermatitis	5.12e-05	0.00123	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	5.09e-05	0.00122	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCL11—atopic dermatitis	5.07e-05	0.00121	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.03e-05	0.00121	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—NPS—atopic dermatitis	5.03e-05	0.0012	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—TAC1—atopic dermatitis	5.03e-05	0.0012	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FCER2—atopic dermatitis	5e-05	0.0012	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—CCL5—atopic dermatitis	5e-05	0.0012	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—CCR5—atopic dermatitis	4.96e-05	0.00119	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CXCL10—atopic dermatitis	4.94e-05	0.00118	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CXCR3—atopic dermatitis	4.93e-05	0.00118	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—CCL5—atopic dermatitis	4.9e-05	0.00117	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCR3—atopic dermatitis	4.85e-05	0.00116	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL27—atopic dermatitis	4.84e-05	0.00116	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CCR3—atopic dermatitis	4.83e-05	0.00116	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—CCR5—atopic dermatitis	4.77e-05	0.00114	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—NPS—atopic dermatitis	4.74e-05	0.00114	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—TAC1—atopic dermatitis	4.74e-05	0.00114	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—IL5—atopic dermatitis	4.67e-05	0.00112	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	4.65e-05	0.00111	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL22—atopic dermatitis	4.65e-05	0.00111	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL17—atopic dermatitis	4.61e-05	0.0011	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NPS—atopic dermatitis	4.59e-05	0.0011	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TAC1—atopic dermatitis	4.59e-05	0.0011	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—NPS—atopic dermatitis	4.57e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—TAC1—atopic dermatitis	4.57e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CCR3—atopic dermatitis	4.55e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—CCR5—atopic dermatitis	4.5e-05	0.00108	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CXCR3—atopic dermatitis	4.5e-05	0.00108	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CXCR3—atopic dermatitis	4.48e-05	0.00107	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—CCR5—atopic dermatitis	4.41e-05	0.00106	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—IL5—atopic dermatitis	4.41e-05	0.00106	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCL11—atopic dermatitis	4.4e-05	0.00105	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL17—atopic dermatitis	4.34e-05	0.00104	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.34e-05	0.00104	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FCER2—atopic dermatitis	4.34e-05	0.00104	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TAC1—atopic dermatitis	4.33e-05	0.00104	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NPS—atopic dermatitis	4.33e-05	0.00104	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—TAC1—atopic dermatitis	4.31e-05	0.00103	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—NPS—atopic dermatitis	4.31e-05	0.00103	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL5—atopic dermatitis	4.26e-05	0.00102	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CCL5—atopic dermatitis	4.25e-05	0.00102	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL5—atopic dermatitis	4.24e-05	0.00102	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCR3—atopic dermatitis	4.24e-05	0.00102	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCR3—atopic dermatitis	4.22e-05	0.00101	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL27—atopic dermatitis	4.14e-05	0.000992	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCR3—atopic dermatitis	4.13e-05	0.00099	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—KIF3A—atopic dermatitis	4.1e-05	0.000983	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.1e-05	0.000981	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—NPS—atopic dermatitis	4.06e-05	0.000972	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—TAC1—atopic dermatitis	4.06e-05	0.000972	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL22—atopic dermatitis	4.04e-05	0.000967	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL5—atopic dermatitis	4.02e-05	0.000963	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL5—atopic dermatitis	4e-05	0.000959	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.99e-05	0.000955	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCR3—atopic dermatitis	3.98e-05	0.000953	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CCR3—atopic dermatitis	3.95e-05	0.000947	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KIF3A—atopic dermatitis	3.87e-05	0.000927	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CCR5—atopic dermatitis	3.83e-05	0.000918	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—IL5—atopic dermatitis	3.77e-05	0.000903	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.76e-05	0.0009	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL17—atopic dermatitis	3.72e-05	0.00089	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CMA1—atopic dermatitis	3.71e-05	0.000889	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL11—atopic dermatitis	3.71e-05	0.000889	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	3.7e-05	0.000885	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—NPS—atopic dermatitis	3.68e-05	0.000882	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TAC1—atopic dermatitis	3.68e-05	0.000882	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CXCL10—atopic dermatitis	3.64e-05	0.000871	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CXCL10—atopic dermatitis	3.62e-05	0.000867	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCR3—atopic dermatitis	3.61e-05	0.000865	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL27—atopic dermatitis	3.6e-05	0.000862	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCR3—atopic dermatitis	3.59e-05	0.00086	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—TAC1—atopic dermatitis	3.52e-05	0.000844	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—NPS—atopic dermatitis	3.52e-05	0.000844	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.5e-05	0.000839	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CMA1—atopic dermatitis	3.5e-05	0.000839	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL11—atopic dermatitis	3.5e-05	0.000839	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—STAT6—atopic dermatitis	3.49e-05	0.000836	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.45e-05	0.000827	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CCL5—atopic dermatitis	3.43e-05	0.000822	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCL10—atopic dermatitis	3.43e-05	0.000821	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL5—atopic dermatitis	3.42e-05	0.00082	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCL10—atopic dermatitis	3.41e-05	0.000818	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KIF3A—atopic dermatitis	3.31e-05	0.000793	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—CXCL8—atopic dermatitis	3.31e-05	0.000792	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.29e-05	0.000789	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—STAT6—atopic dermatitis	3.29e-05	0.000788	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—IL6—atopic dermatitis	3.28e-05	0.000785	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—IL5—atopic dermatitis	3.27e-05	0.000784	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CCL5—atopic dermatitis	3.24e-05	0.000775	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL17—atopic dermatitis	3.23e-05	0.000773	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCL10—atopic dermatitis	3.22e-05	0.00077	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TAC1—atopic dermatitis	3.2e-05	0.000766	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—NPS—atopic dermatitis	3.2e-05	0.000766	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—CXCL8—atopic dermatitis	3.18e-05	0.000761	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCR3—atopic dermatitis	3.14e-05	0.000751	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CCL5—atopic dermatitis	3.13e-05	0.000749	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—CXCL8—atopic dermatitis	3.12e-05	0.000747	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CCL5—atopic dermatitis	3.12e-05	0.000746	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CCR5—atopic dermatitis	3.09e-05	0.00074	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.04e-05	0.000729	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—IL2—atopic dermatitis	3.04e-05	0.000727	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCR3—atopic dermatitis	3.03e-05	0.000725	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—CXCL8—atopic dermatitis	3e-05	0.000718	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL11—atopic dermatitis	2.99e-05	0.000717	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CMA1—atopic dermatitis	2.99e-05	0.000717	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.98e-05	0.000714	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL5—atopic dermatitis	2.97e-05	0.000712	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCL5—atopic dermatitis	2.95e-05	0.000707	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CCL5—atopic dermatitis	2.94e-05	0.000704	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCL10—atopic dermatitis	2.92e-05	0.000699	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CCR5—atopic dermatitis	2.91e-05	0.000698	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NGF—atopic dermatitis	2.9e-05	0.000694	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—CXCL8—atopic dermatitis	2.89e-05	0.000691	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KIF3A—atopic dermatitis	2.88e-05	0.000689	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—IL2—atopic dermatitis	2.86e-05	0.000686	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCR3—atopic dermatitis	2.85e-05	0.000684	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CCR5—atopic dermatitis	2.82e-05	0.000675	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—STAT6—atopic dermatitis	2.82e-05	0.000674	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CCR5—atopic dermatitis	2.81e-05	0.000672	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.79e-05	0.000669	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CCL5—atopic dermatitis	2.77e-05	0.000663	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL2—atopic dermatitis	2.76e-05	0.00066	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NGF—atopic dermatitis	2.73e-05	0.000655	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—CXCL8—atopic dermatitis	2.72e-05	0.000652	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NPS—atopic dermatitis	2.7e-05	0.000646	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TAC1—atopic dermatitis	2.7e-05	0.000646	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—CXCL8—atopic dermatitis	2.67e-05	0.000639	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCR5—atopic dermatitis	2.66e-05	0.000637	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.66e-05	0.000637	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CCR5—atopic dermatitis	2.65e-05	0.000634	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCR3—atopic dermatitis	2.65e-05	0.000634	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL2—atopic dermatitis	2.6e-05	0.000623	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL11—atopic dermatitis	2.6e-05	0.000623	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CMA1—atopic dermatitis	2.6e-05	0.000623	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NPS—atopic dermatitis	2.54e-05	0.000609	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TAC1—atopic dermatitis	2.54e-05	0.000609	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL10—atopic dermatitis	2.54e-05	0.000607	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCL5—atopic dermatitis	2.51e-05	0.000602	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL5—atopic dermatitis	2.51e-05	0.000601	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCR3—atopic dermatitis	2.49e-05	0.000597	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CCR5—atopic dermatitis	2.49e-05	0.000597	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—STAT6—atopic dermatitis	2.45e-05	0.000586	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR3—atopic dermatitis	2.44e-05	0.000585	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CCL5—atopic dermatitis	2.4e-05	0.000576	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NFKBIA—atopic dermatitis	2.39e-05	0.000572	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL5—atopic dermatitis	2.36e-05	0.000566	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CXCL8—atopic dermatitis	2.32e-05	0.000555	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.31e-05	0.000553	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCR5—atopic dermatitis	2.26e-05	0.000542	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NFKBIA—atopic dermatitis	2.25e-05	0.00054	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCL5—atopic dermatitis	2.18e-05	0.000523	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TAC1—atopic dermatitis	2.18e-05	0.000521	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NPS—atopic dermatitis	2.18e-05	0.000521	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CCR5—atopic dermatitis	2.17e-05	0.000519	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL10—atopic dermatitis	2.14e-05	0.000512	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCR3—atopic dermatitis	2.13e-05	0.000511	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	2.12e-05	0.000508	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL5—atopic dermatitis	2.02e-05	0.000485	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	2.02e-05	0.000483	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	1.97e-05	0.000471	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	1.89e-05	0.000453	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NPS—atopic dermatitis	1.89e-05	0.000453	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.87e-05	0.000448	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	1.85e-05	0.000444	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	1.84e-05	0.000441	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	1.79e-05	0.000428	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.76e-05	0.000422	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL5—atopic dermatitis	1.76e-05	0.000421	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL5—atopic dermatitis	1.74e-05	0.000416	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	1.72e-05	0.000413	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NGF—atopic dermatitis	1.7e-05	0.000408	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CXCL8—atopic dermatitis	1.7e-05	0.000408	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.7e-05	0.000406	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	1.68e-05	0.000403	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	1.66e-05	0.000397	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL2—atopic dermatitis	1.63e-05	0.00039	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	1.62e-05	0.000388	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL6—atopic dermatitis	1.62e-05	0.000388	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCL8—atopic dermatitis	1.61e-05	0.000385	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NGF—atopic dermatitis	1.61e-05	0.000385	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	1.6e-05	0.000383	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.59e-05	0.000381	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCR5—atopic dermatitis	1.56e-05	0.000375	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL2—atopic dermatitis	1.54e-05	0.000368	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL2—atopic dermatitis	1.53e-05	0.000366	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL6—atopic dermatitis	1.53e-05	0.000366	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.53e-05	0.000365	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.51e-05	0.000361	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MAPK8—atopic dermatitis	1.5e-05	0.000359	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	1.5e-05	0.000359	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	1.48e-05	0.000356	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	1.44e-05	0.000345	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MAPK8—atopic dermatitis	1.41e-05	0.000339	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	1.41e-05	0.000337	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	1.38e-05	0.000329	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	1.37e-05	0.000328	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	1.34e-05	0.00032	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	1.33e-05	0.000318	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.31e-05	0.000314	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	1.31e-05	0.000313	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	1.29e-05	0.000309	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	1.25e-05	0.0003	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	1.19e-05	0.000286	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	1.19e-05	0.000285	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	1.16e-05	0.000278	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	1.14e-05	0.000272	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	1.13e-05	0.000272	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	1e-05	0.00024	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	9.85e-06	0.000236	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL2—atopic dermatitis	9.58e-06	0.000229	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—atopic dermatitis	9.57e-06	0.000229	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	9.53e-06	0.000228	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	9.45e-06	0.000226	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL2—atopic dermatitis	9.03e-06	0.000216	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—atopic dermatitis	9.03e-06	0.000216	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—atopic dermatitis	8.99e-06	0.000215	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	8.82e-06	0.000211	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	8.32e-06	0.000199	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	8.09e-06	0.000194	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	7.73e-06	0.000185	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	7.69e-06	0.000184	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	7.11e-06	0.00017	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	7.02e-06	0.000168	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	6.71e-06	0.000161	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	6.68e-06	0.00016	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	6.18e-06	0.000148	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—atopic dermatitis	5.63e-06	0.000135	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—atopic dermatitis	5.31e-06	0.000127	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPARA—atopic dermatitis	5.16e-06	0.000124	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	4.54e-06	0.000109	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	3.95e-06	9.45e-05	CbGpPWpGaD
